---
title: "Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study | ONCY Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284212289.md"
description: "Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study | ONCY Stock News"
datetime: "2026-04-27T04:10:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284212289.md)
  - [en](https://longbridge.com/en/news/284212289.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284212289.md)
---

# Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study | ONCY Stock News

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study | ONCY Stock News

### Related Stocks

- [ONCY.US](https://longbridge.com/en/quote/ONCY.US.md)

## Related News & Research

- [Oncolytics Biotech® Reports Durable Responses In Second-Line Ras-Mutant Mss Colorectal Cancer](https://longbridge.com/en/news/285077428.md)
- [Stocks in Play: Oncolytics Biotech Inc](https://longbridge.com/en/news/284230718.md)
- [AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios](https://longbridge.com/en/news/286801629.md)
- [Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System | AORT Stock News](https://longbridge.com/en/news/286759671.md)
- [Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) | NTRA Stock News](https://longbridge.com/en/news/286594638.md)